Table 3.
Timing of adverse events by baseline characteristics*
| Adverse event and baseline characteristic | Median day without characteristic (and interquartile range) | Median day with characteristic (and interquartile range) | p value |
|---|---|---|---|
| Stroke | |||
| No associations | – | – | – |
| Myocardial infarction | |||
| Female | 3 (2–8) | 2 (1–4) | < 0.001 |
| Pulmonary embolism | |||
| Dependent status (versus independent) | 3 (2–7) | 16 (7–20) | 0.004 |
| TKA† | 5 (3–17) | 3 (2–6) | < 0.001 |
| Pneumonia | |||
| Dyspnea on exertion | 6 (3–12) | 5 (3–11) | 0.002 |
| General anesthesia (versus regional) | 3 (2–8) | 9 (3–15) | 0.001 |
| Deep vein thrombosis | |||
| TKA† | 13 (6–22) | 5 (2–11) | < 0.001 |
| Urinary tract infection | |||
| Obese (BMI ≥ 30 kg/m2) | 9 (4–17) | 7 (3–15) | 0.004 |
| Sepsis | |||
| No associations | – | – | – |
| Surgical site infection | |||
| Obese (BMI ≥ 30 kg/m2) | 15 (9–22) | 17 (12–23) | < 0.001 |
| TKA† | 17 (13–23) | 16 (10–23) | 0.008 |
* Only statistically significant associations are shown; †in comparison with THA; BMI = body mass index.